Metropolitan Life Insurance Company (MetLife)’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-465
| Closed | -$92.3K | – | 2828 |
|
|
2021
Q3 | $92.3K | Buy |
+465
| New | +$92.3K | ﹤0.01% | 2566 |
|
|
2021
Q2 | – | Sell |
-482
| Closed | -$95.3K | – | 2871 |
|
|
2021
Q1 | $95.3K | Sell |
482
-71
| -13% | -$14K | ﹤0.01% | 2438 |
|
|
2020
Q4 | $109K | Hold |
553
| – | – | ﹤0.01% | 2316 |
|
|
2020
Q3 | $98K | Sell |
553
-3
| -0.5% | -$532 | ﹤0.01% | 2231 |
|
|
2020
Q2 | $129K | Buy |
+556
| New | +$129K | ﹤0.01% | 2100 |
|
|
2019
Q4 | – | Sell |
-411
| Closed | -$78.9K | – | 2558 |
|
|
2019
Q3 | $78.9K | Buy |
+411
| New | +$78.9K | ﹤0.01% | 2430 |
|